Production (Stage)
Bruker Corporation
BRKR
$35.50
-$0.84-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -18.19% | 13.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.19% | 13.33% | |||
| Cost of Revenue | -15.74% | 9.92% | |||
| Gross Profit | -20.56% | 16.82% | |||
| SG&A Expenses | -7.41% | 6.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 128.47% | -213.22% | |||
| Total Operating Expenses | -10.24% | 4.86% | |||
| Operating Income | -57.81% | 89.58% | |||
| Income Before Tax | -53.30% | -0.91% | |||
| Income Tax Expenses | -78.62% | 175.00% | |||
| Earnings from Continuing Operations | 20.86% | -65.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 400.00% | -133.33% | |||
| Net Income | 27.01% | -66.50% | |||
| EBIT | -57.81% | 89.58% | |||
| EBITDA | -44.85% | 57.71% | |||
| EPS Basic | 26.99% | -66.52% | |||
| Normalized Basic EPS | -57.28% | 95.98% | |||
| EPS Diluted | 21.68% | -66.52% | |||
| Normalized Diluted EPS | -57.24% | 96.12% | |||
| Average Basic Shares Outstanding | 0.00% | 0.07% | |||
| Average Diluted Shares Outstanding | -0.07% | 0.00% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.20% | 1.99% | |||